These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 27725385)
1. [Development of Novel Diagnostic Agents for Atherosclerosis Using Fluorescence-labeled Peptides]. Sato A Yakugaku Zasshi; 2016; 136(10):1367-1372. PubMed ID: 27725385 [TBL] [Abstract][Full Text] [Related]
2. Highly stable, fluorescence-labeled heptapeptides substituted with a D-amino acid for the specific detection of oxidized low-density lipoprotein in plasma. Sato A; Yamanaka H; Oe K; Yokoyama I; Yamazaki Y; Ebina K Chem Biol Drug Des; 2015 Mar; 85(3):348-55. PubMed ID: 25066364 [TBL] [Abstract][Full Text] [Related]
3. A Fluorescence-Labeled Heptapeptide, (FITC)KP6, as an Efficient Probe for the Specific Detection of Oxidized and Minimally Modified Low-Density Lipoprotein. Sato A; Ueda C; Kimura R; Kobayashi C; Yamazaki Y; Ebina K J Fluoresc; 2016 May; 26(3):1141-50. PubMed ID: 27063871 [TBL] [Abstract][Full Text] [Related]
4. A fluorescently labeled undecapeptide derived from a protein in royal jelly of the honeybee-royalisin-for specific detection of oxidized low-density lipoprotein. Sato A; Unuma H; Yamazaki Y; Ebina K J Pept Sci; 2018 Jun; 24(4-5):e3072. PubMed ID: 29602217 [TBL] [Abstract][Full Text] [Related]
5. Novel fluorescently labeled peptide compounds for detection of oxidized low-density lipoprotein at high specificity. Sato A; Yamanaka H; Oe K; Yamazaki Y; Ebina K Chem Biol Drug Des; 2014 Oct; 84(4):443-9. PubMed ID: 24717143 [TBL] [Abstract][Full Text] [Related]
6. A Method for In Vitro Measurement of Oxidized Low-Density Lipoprotein in Blood, Using Its Antibody, Fluorescence-Labeled Heptapeptide and Polyethylene Glycol. Sato A; Yamazaki Y; Ebina K J Fluoresc; 2017 Nov; 27(6):1985-1993. PubMed ID: 28687985 [TBL] [Abstract][Full Text] [Related]
7. Profile of IL-6 and TNF in Foam Cell Formation: An Improved Method Using Fluorescein Isothiocyanate (FITC) Probe. Castro CA; Buzinari TC; Lino RLB; Araújo HSS; Aníbal FF; Verzola RMM; Bagnato VS; Inada NM; Rodrigues GJ Arq Bras Cardiol; 2022 Oct; 119(4):533-541. PubMed ID: 35946754 [TBL] [Abstract][Full Text] [Related]
8. Human estrogen sulfotransferase and its related fluorescently labeled decapeptides specifically interact with oxidized low-density lipoprotein. Sato A; Yamazaki M; Watanabe H; Sakurai E; Ebina K J Pept Sci; 2020 Oct; 26(10):e3274. PubMed ID: 32633098 [TBL] [Abstract][Full Text] [Related]
9. Biotinylated heptapeptides substituted with a D-amino acid as platelet-activating factor inhibitors. Sato A; Yokoyama I; Ebina K Eur J Pharmacol; 2015 Oct; 764():202-207. PubMed ID: 26142829 [TBL] [Abstract][Full Text] [Related]
10. [Front line of oxidized lipoproteins: role of oxidized lipoproteins in atherogenesis and cardiovascular disease risk]. Yoshida H Rinsho Byori; 2010 Jun; 58(6):622-30. PubMed ID: 20662275 [TBL] [Abstract][Full Text] [Related]
11. The oxidative modification hypothesis of atherosclerosis: the comparison of atherogenic effects on oxidized LDL and remnant lipoproteins in plasma. Nakajima K; Nakano T; Tanaka A Clin Chim Acta; 2006 May; 367(1-2):36-47. PubMed ID: 16448638 [TBL] [Abstract][Full Text] [Related]
12. Detection of vulnerable coronary plaques by color fluorescent angioscopy. Uchida Y; Uchida Y; Kawai S; Kanamaru R; Sugiyama Y; Tomaru T; Maezawa Y; Kameda N JACC Cardiovasc Imaging; 2010 Apr; 3(4):398-408. PubMed ID: 20394902 [TBL] [Abstract][Full Text] [Related]
13. The role of oxidized lipoproteins in the pathogenesis of atherosclerosis. Kita T; Yokode M; Ishii K; Kume N; Nagano Y; Arai H; Otani H; Ueda Y; Hara S Clin Exp Pharmacol Physiol Suppl; 1992; 20():37-42. PubMed ID: 1446408 [TBL] [Abstract][Full Text] [Related]
15. Myricitrin attenuates endothelial cell apoptosis to prevent atherosclerosis: An insight into PI3K/Akt activation and STAT3 signaling pathways. Qin M; Luo Y; Meng XB; Wang M; Wang HW; Song SY; Ye JX; Pan RL; Yao F; Wu P; Sun GB; Sun XB Vascul Pharmacol; 2015 Jul; 70():23-34. PubMed ID: 25849952 [TBL] [Abstract][Full Text] [Related]
16. Effects of oxidized low density lipoprotein on the growth of human artery smooth muscle cells. Zhao GF; Seng JJ; Zhang H; She MP Chin Med J (Engl); 2005 Dec; 118(23):1973-8. PubMed ID: 16336833 [TBL] [Abstract][Full Text] [Related]
17. Oxidized low-density lipoprotein levels circulating in plasma and deposited in the tissues: comparison between Helicobacter pylori-associated gastritis and acute myocardial infarction. Kayo S; Ohsawa M; Ehara S; Naruko T; Ikura Y; Hai E; Yoshimi N; Shirai N; Tsukamoto Y; Itabe H; Higuchi K; Arakawa T; Ueda M Am Heart J; 2004 Nov; 148(5):818-25. PubMed ID: 15523312 [TBL] [Abstract][Full Text] [Related]
18. Oxidized LDL-induced JAB1 influences NF-κB independent inflammatory signaling in human macrophages during foam cell formation. Schwarz A; Bonaterra GA; Schwarzbach H; Kinscherf R J Biomed Sci; 2017 Feb; 24(1):12. PubMed ID: 28173800 [TBL] [Abstract][Full Text] [Related]
19. Anti-atherosclerotic potential of gossypetin via inhibiting LDL oxidation and foam cell formation. Chen JH; Tsai CW; Wang CP; Lin HH Toxicol Appl Pharmacol; 2013 Oct; 272(2):313-24. PubMed ID: 23845592 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of Orai1 Store-Operated Calcium Channel Prevents Foam Cell Formation and Atherosclerosis. Liang SJ; Zeng DY; Mai XY; Shang JY; Wu QQ; Yuan JN; Yu BX; Zhou P; Zhang FR; Liu YY; Lv XF; Liu J; Ou JS; Qian JS; Zhou JG Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):618-28. PubMed ID: 26916730 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]